The role of CD4+ cells in sustaining lymphocyte proliferation during lymphocytic choriomeningitis virus infection.

PubWeight™: 1.26‹?› | Rank: Top 10%

🔗 View Article (PMID 1672337)

Published in J Immunol on March 15, 1991

Authors

M T Kasaian1, K A Leite-Morris, C A Biron

Author Affiliations

1: Division of Biology and Medicine, Brown University, Providence, RI 02912.

Articles citing this

CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol (1994) 10.03

CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge. J Virol (1996) 3.39

CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response. J Exp Med (1996) 2.21

A role for CD4+ NK1.1+ T lymphocytes as major histocompatibility complex class II independent helper cells in the generation of CD8+ effector function against intracellular infection. J Exp Med (1996) 1.70

CD40 ligand-mediated interactions are involved in the generation of memory CD8(+) cytotoxic T lymphocytes (CTL) but are not required for the maintenance of CTL memory following virus infection. J Virol (1998) 1.53

CD4(+) T cell subsets during virus infection. Protective capacity depends on effector cytokine secretion and on migratory capability. J Exp Med (2000) 1.29

Both CD4+ and CD8+ T cells are involved in protection against HSV-1 induced corneal scarring. Br J Ophthalmol (2000) 1.12

Anti-glycoprotein D monoclonal antibody protects against herpes simplex virus type 1-induced diseases in mice functionally depleted of selected T-cell subsets or asialo GM1+ cells. J Virol (1991) 1.03

Modulation by gamma interferon of antiviral cell-mediated immune responses in vivo. J Virol (1996) 0.98

Focal expression of interleukin-2 does not break unresponsiveness to "self" (viral) antigen expressed in beta cells but enhances development of autoimmune disease (diabetes) after initiation of an anti-self immune response. J Clin Invest (1995) 0.95

Activated regulatory T cells suppress effector NK cell responses by an IL-2-mediated mechanism during an acute retroviral infection. Retrovirology (2015) 0.80

T cell state transition produces an emergent change detector. J Theor Biol (2011) 0.78

Articles by these authors

Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J Exp Med (1995) 3.40

Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J Immunol (1996) 3.30

The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions. Brain Res Brain Res Rev (1997) 3.23

An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J Immunol (1996) 3.09

Two roads diverged: interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection. J Exp Med (1999) 2.98

SAP controls T cell responses to virus and terminal differentiation of TH2 cells. Nat Immunol (2001) 2.95

Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP. Proc Natl Acad Sci U S A (2000) 2.80

Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox. Nat Immunol (2000) 2.75

Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection. Proc Natl Acad Sci U S A (1997) 2.46

Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism. J Virol (2000) 2.41

Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways. J Exp Med (1998) 2.34

Effects of IL-12 on the response and susceptibility to experimental viral infections. J Immunol (1994) 2.31

Characterization of early cytokine responses and an interleukin (IL)-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection. J Exp Med (1997) 2.14

A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense. J Clin Invest (2000) 1.97

Endogenous IL-2 contributes to T cell expansion and IFN-gamma production during lymphocytic choriomeningitis virus infection. J Immunol (1995) 1.84

Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids. J Exp Med (1995) 1.80

Blastogenesis of natural killer cells during viral infection in vivo. J Immunol (1982) 1.72

Increase in NK cell number and turnover rate during acute viral infection. J Immunol (1983) 1.65

Cutting edge: selective IL-18 requirements for induction of compartmental IFN-gamma responses during viral infection. J Immunol (2000) 1.63

Prevention of diabetes in BioBreeding/Worcester rats with monoclonal antibodies that recognize T lymphocytes or natural killer cells. J Exp Med (1986) 1.57

Infection of neonatal mice with sindbis virus results in a systemic inflammatory response syndrome. J Virol (1999) 1.56

Mapping of a major genetic modifier of embryonic lethality in TGF beta 1 knockout mice. Nat Genet (1997) 1.51

Replication of murine cytomegalovirus in differentiated macrophages as a determinant of viral pathogenesis. J Virol (1999) 1.42

NK cell functions restrain T cell responses during viral infections. Eur J Immunol (2001) 1.41

Synergism for cytokine-mediated disease during concurrent endotoxin and viral challenges: roles for NK and T cell IFN-gamma production. J Immunol (1999) 1.39

CD4+ and CD8+ T cell interactions in IFN-gamma and IL-4 responses to viral infections: requirements for IL-2. J Immunol (1998) 1.38

NK cell trafficking and cytokine expression in splenic compartments after IFN induction and viral infection. J Immunol (1996) 1.35

Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus. J Immunol (1983) 1.35

Generation of large granular T lymphocytes in vivo during viral infection. J Immunol (1986) 1.33

Interferon induces natural killer cell blastogenesis in vivo. J Leukoc Biol (1984) 1.30

Endogenous glucocorticoids protect against cytokine-mediated lethality during viral infection. J Immunol (1999) 1.26

Compartmental differences in NK cell responsiveness to IL-12 during lymphocytic choriomeningitis virus infection. J Immunol (2000) 1.25

A role for transforming growth factor-beta 1 in regulating natural killer cell and T lymphocyte proliferative responses during acute infection with lymphocytic choriomeningitis virus. J Immunol (1991) 1.19

Murine natural killer cells stimulated in vivo do not express the T cell receptor alpha, beta, gamma, T3 delta, or T3 epsilon genes. J Immunol (1987) 1.18

Interferon beta in multiple sclerosis: is IL-12 suppression the key? Immunol Today (2000) 1.17

The activation of IL-2 transcription in L3T4+ and Lyt-2+ lymphocytes during virus infection in vivo. J Immunol (1989) 1.14

Mechanisms for virus-induced liver disease: tumor necrosis factor-mediated pathology independent of natural killer and T cells during murine cytomegalovirus infection. J Virol (1997) 1.09

Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4. Int Immunol (2000) 1.05

IFN induction and associated changes in splenic leukocyte distribution. J Immunol (1993) 1.04

Activation and role of natural killer cells in virus infections. Med Microbiol Immunol (1982) 1.04

IL-2-dependent NK cell responses discovered in virus-infected beta 2-microglobulin-deficient mice. J Immunol (1994) 1.03

Transforming growth factor-beta expression and natural killer cell responses during virus infection of normal, nude, and SCID mice. J Immunol (1993) 1.02

Role of adenosine A1 and A2A receptors in the alcohol withdrawal syndrome. Alcohol (1999) 1.00

Natural killer cell development is blocked in the context of aberrant T lymphocyte ontogeny. Int Immunol (1996) 0.97

Effects of cyclosporin A on IL-2 production and lymphocyte proliferation during infection of mice with lymphocytic choriomeningitis virus. J Immunol (1990) 0.96

Role of natural killer cells in virus infections of mice. Surv Synth Pathol Res (1984) 0.95

Natural killer cell number and function in the spontaneously diabetic BB/W rat. J Immunol (1986) 0.94

Purification and target cell range of in vivo elicited blast natural killer cells. J Immunol (1986) 0.92

Blastogenesis of large granular lymphocytes in nonlymphoid organs. J Leukoc Biol (1988) 0.90

Baclofen enhances extinction of opiate conditioned place preference. Behav Brain Res (2009) 0.89

Changes in expression of c-Fos protein following cocaine-cue extinction learning. Behav Brain Res (2012) 0.87

Aberrant T cells in beige mutant mice. J Immunol (1987) 0.86

1996 Curt P. Richter Award. Effects of viral infection on corticosterone secretion and glucocorticoid receptor binding in immune tissues. Psychoneuroendocrinology (1997) 0.85

Lysis of uninfected and virus-infected cells in vivo: a rejection mechanism in addition to that mediated by natural killer cells. J Virol (1984) 0.85

Cyclosporin A inhibition of interleukin 2 gene expression, but not natural killer cell proliferation, after interferon induction in vivo. J Exp Med (1990) 0.85

Mononuclear phagocyte maturation: a cytotoxic monoclonal antibody reactive with postmonoblast stages. Cell Immunol (1984) 0.85

Alterations of adenosine A1 receptors in morphine dependence. Brain Res (1994) 0.84

Alterations in expression and phosphorylation of GluA1 receptors following cocaine-cue extinction learning. Behav Brain Res (2012) 0.82

Differential effects of treatment with typical and atypical antipsychotic drugs on adenylyl cyclase and G proteins. Neurosci Lett (1999) 0.80

Up-regulation of adenosine transporter-binding sites in striatum and hypothalamus of opiate tolerant mice. Brain Res (1997) 0.80

Regulation of G protein-mediated adenylyl cyclase in striatum and cortex of opiate-dependent and opiate withdrawing mice. Brain Res (1998) 0.79

Interferon production and activation of non-specific effector cells by stimulation with lymphoblastoid cell lines in vitro. Int J Cancer (1981) 0.77

Neuroendocrine-immune interactions during viral infections. Adv Virus Res (2001) 0.76

Generation of antigen-specific cytotoxic T lymphocytes and regulation of cytokine production takes place in the absence of CD3zeta. Int Immunol (1999) 0.76

Cloned endothelium derived from autoimmune vascular disease retain structural and functional characteristics of normal endothelial cells. Exp Cell Res (1992) 0.75